Figure 5: Possible options for intervention in different stages of rheumatoid arthritis pathogenesis. The review is based on data obtained from a structured but not fully systematic review of the ...

The management of rheumatoid arthritis (RA) with biological response ... and interleukin-1 (IL-1), play a critical role in the pathogenesis of this disorder. IL-1-receptor antagonist (IL-1Ra ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Rheumatoid arthritis (RA) remains a uniquely human ... in vivo animal experiments and our understanding of the pathogenesis of RA. The risk of toxicity and inadequate efficacy in human trials ...

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

20. Barrera P, Fauré S, Prud'homme JF, et al. European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin Exp Rheumatol 2001; 19: ...

Dr. Kavanaugh's clinical research primarily explores rheumatoid arthritis and psoriatic arthritis, focusing on their pathophysiology and the effects of novel immunomodulatory therapies.

Recent research explores how gut microbiome imbalances contribute to rheumatoid arthritis, and how dietary interventions could be key to reducing inflammation and improving patient outcomes.

Steroids are powerful anti-inflammatory drugs that can treat many forms of arthritis, including rheumatoid arthritis, lupus, and other forms of inflammation such as vasculitis. Although effective ...